Much more than you expected: The non-DHFR-mediated effects of methotrexate.

[1]  P. Abraham,et al.  Methotrexate administration induces differential and selective protein tyrosine nitration and cysteine nitrosylation in the subcellular organelles of the small intestinal mucosa of rats. , 2016, Chemico-biological interactions.

[2]  J. Štěrba,et al.  Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation , 2016, Cancer Cell International.

[3]  J. Boyle,et al.  Methotrexate-mediated activation of an AMPK-CREB-dependent pathway: a novel mechanism for vascular protection in chronic systemic inflammation , 2014, Annals of the rheumatic diseases.

[4]  A. Ghahary,et al.  Methotrexate modulates the expression of MMP-1 and type 1 collagen in dermal fibroblast , 2015, Molecular and Cellular Biochemistry.

[5]  Stephen Brown,et al.  Methotrexate Is a JAK/STAT Pathway Inhibitor , 2015, PloS one.

[6]  A. Cribbs,et al.  Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis , 2015, Arthritis & rheumatology.

[7]  J. Štěrba,et al.  DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines , 2015, Oncology reports.

[8]  N. Olsen,et al.  Methotrexate-mediated inhibition of nuclear factor κB activation by distinct pathways in T cells and fibroblast-like synoviocytes. , 2015, Rheumatology.

[9]  G. Wood,et al.  Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy. , 2014, Archives of biochemistry and biophysics.

[10]  H. Sousa,et al.  SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients. , 2014, Toxicological sciences : an official journal of the Society of Toxicology.

[11]  K. Chang,et al.  Effect of polymorphisms within methotrexate pathway genes on methotrexate toxicity and plasma levels in adults with hematological malignancies. , 2014, Pharmacogenomics.

[12]  H. Sousa,et al.  Role of Key TYMS Polymorphisms on Methotrexate Therapeutic Outcome in Portuguese Rheumatoid Arthritis Patients , 2014, PloS one.

[13]  H. Aburatani,et al.  Methionine metabolism regulates maintenance and differentiation of human pluripotent stem cells. , 2014, Cell metabolism.

[14]  H. Abaan,et al.  Genomics of CpG Methylation in Developing and Developed Zebrafish , 2014, G3: Genes, Genomes, Genetics.

[15]  N. Olsen,et al.  Methotrexate induces production of IL-1 and IL-6 in the monocytic cell line U937 , 2014, Arthritis Research & Therapy.

[16]  R. Johnstone,et al.  New and emerging HDAC inhibitors for cancer treatment. , 2014, The Journal of clinical investigation.

[17]  H. Sousa,et al.  SLC 19 A 1 , SLC 46 A 1 and SLCO 1 B 1 Polymorphisms as Predictors of Methotrexate-Related Toxicity in Portuguese Rheumatoid Arthritis Patients , 2014 .

[18]  P. Gnanaraj,et al.  Impact of methotrexate on oxidative stress and apoptosis markers in psoriatic patients , 2014, Clinical and Experimental Medicine.

[19]  H. Saya,et al.  Identification of novel small compounds that restore E-cadherin expression and inhibit tumor cell motility and invasiveness. , 2013, Biochemical pharmacology.

[20]  W. Lems,et al.  Methotrexate normalizes up-regulated folate pathway genes in rheumatoid arthritis. , 2013, Arthritis and rheumatism.

[21]  M. Becker,et al.  Low-Dose Methotrexate Results in the Selective Accumulation of Aminoimidazole Carboxamide Ribotide in an Erythroblastoid Cell Line , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[22]  M. Middleton,et al.  Directed phenotype switching as an effective antimelanoma strategy. , 2013, Cancer cell.

[23]  D. Arnett,et al.  Markers of Treatment Response to Methotrexate in Rheumatoid Arthritis: Where Do We Stand? , 2012, International journal of rheumatology.

[24]  M. Montenegro,et al.  Melanoma coordinates general and cell-specific mechanisms to promote methotrexate resistance. , 2012, Experimental cell research.

[25]  E. Chiang,et al.  Low-Dose Methotrexate Inhibits Methionine S-Adenosyltransferase In Vitro and In Vivo , 2012, Molecular medicine.

[26]  K. S. Hall,et al.  High dose methotrexate chemotherapy: pharmacokinetics, folate and toxicity in osteosarcoma patients. , 2012, British journal of clinical pharmacology.

[27]  J. Neradil,et al.  New mechanisms for an old drug; DHFR- and non-DHFR-mediated effects of methotrexate in cancer cells. , 2012, Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti.

[28]  B. El-fiky,et al.  Influence of anticancer drugs on DNA methylation in liver of female mice , 2011 .

[29]  G. Wood,et al.  Reduction of Fas/CD95 promoter methylation, upregulation of Fas protein, and enhancement of sensitivity to apoptosis in cutaneous T-cell lymphoma. , 2011, Archives of dermatology.

[30]  Pei-Ming Yang,et al.  Methotrexate induces apoptosis through p53/p21-dependent pathway and increases E-cadherin expression through downregulation of HDAC/EZH2. , 2011, Biochemical pharmacology.

[31]  Jung-Hsin Lin,et al.  Inhibition of histone deacetylase activity is a novel function of the antifolate drug methotrexate. , 2010, Biochemical and biophysical research communications.

[32]  E. Tanghetti,et al.  Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In Vitro and In Vivo , 2010 .

[33]  D. Gemmati,et al.  Gene polymorphisms in folate metabolizing enzymes in adult acute lymphoblastic leukemia: effects on methotrexate-related toxicity and survival , 2009, Haematologica.

[34]  A. Ashworth,et al.  Methotrexate induces oxidative DNA damage and is selectively lethal to tumour cells with defects in the DNA mismatch repair gene MSH2 , 2009, EMBO Molecular Medicine.

[35]  T. Hasan,et al.  Low-Dose Methotrexate Enhances Aminolevulinate-Based Photodynamic Therapy in Skin Carcinoma Cells In vitro and In vivo , 2009, Clinical Cancer Research.

[36]  Ming Li,et al.  High-performance capillary electrophoretic method for the quantification of global DNA methylation: application to methotrexate-resistant cells. , 2009, Analytical biochemistry.

[37]  T. Huizinga,et al.  Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis. , 2007, Rheumatology.

[38]  L. Matherly,et al.  Structure and function of the reduced folate carrier a paradigm of a major facilitator superfamily mammalian nutrient transporter. , 2008, Vitamins and hormones.

[39]  Dong Hou Kim,et al.  Methotrexate decreases PP2A methylation and increases tau phosphorylation in neuron. , 2007, Biochemical and biophysical research communications.

[40]  S. Inokuma,et al.  Higher maximal serum concentration of methotrexate predicts the incidence of adverse reactions in Japanese rheumatoid arthritis patients , 2007, Modern rheumatology.

[41]  Richard J. Jones,et al.  Induction of acute lymphocytic leukemia differentiation by maintenance therapy , 2007, Leukemia.

[42]  L. Matherly,et al.  Human reduced folate carrier: translation of basic biology to cancer etiology and therapy , 2007, Cancer and Metastasis Reviews.

[43]  Link,et al.  Inhibition of cytokine production by methotrexate . Studies in healthy volunteers and patients with rheumatoid arthritis , 2007 .

[44]  B. Cronstein,et al.  Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis. , 2007, Bulletin of the NYU hospital for joint diseases.

[45]  D. Barrett,et al.  Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation , 2006, Journal of cellular biochemistry.

[46]  L. Dušek,et al.  Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited. , 2006, Clinical chemistry.

[47]  N. Zurgil,et al.  Low dose methotrexate induces apoptosis with reactive oxygen species involvement in T lymphocytic cell lines to a greater extent than in monocytic lines , 2005, Inflammation Research.

[48]  F. Orosz,et al.  Methotrexate inhibits the glyoxalase system in vivo in children with acute lymphoid leukaemia. , 2004, European journal of cancer.

[49]  Katie Smith,et al.  Polyglutamation of methotrexate with common polymorphisms in reduced folate carrier, aminoimidazole carboxamide ribonucleotide transformylase, and thymidylate synthase are associated with methotrexate effects in rheumatoid arthritis. , 2004, Arthritis and rheumatism.

[50]  M. Mukai,et al.  Pharmacokinetics and efficacy of low-dose methotrexate in patients with rheumatoid arthritis , 2004, Modern rheumatology.

[51]  I. Goldman,et al.  Resistance to antifolates , 2003, Oncogene.

[52]  L. Genestier,et al.  Differential Control of Cell Cycle, Proliferation, and Survival of Primary T Lymphocytes by Purine and Pyrimidine Nucleotides1 , 2003, The Journal of Immunology.

[53]  P. Casey,et al.  Targeting Ras signaling through inhibition of carboxyl methylation: An unexpected property of methotrexate , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[54]  R. Misra,et al.  Methotrexate inhibits interleukin-6 production in patients with juvenile rheumatoid arthritis , 2003, Rheumatology International.

[55]  K. Woollard,et al.  The anti‐inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species , 2003, British journal of pharmacology.

[56]  P. Loetscher,et al.  Effects of methotrexate on differentiation of monocytes and production of cytokine inhibitors by monocytes. , 1998, Arthritis and rheumatism.

[57]  J. Mason,et al.  DNA hypomethylation in inflammatory arthritis: reversal with methotrexate. , 1996, The Journal of laboratory and clinical medicine.

[58]  C. Wagner,et al.  DNA methylation in folate deficiency: use of CpG methylase. , 1993, Biochemical and biophysical research communications.

[59]  E. Atillasoy,et al.  Methotrexate induces differentiation of human keratinocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.